{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T07:39:01Z","timestamp":1773041941512,"version":"3.50.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>With health systems facing increasing challenges, it is important to define new care models that may release some of the burden on the workforce, whilst maintaining quality and improving patient convenience. The objective of this study was to create a taxonomy of pharmacist-led interventions aimed at supporting improved health outcomes of people self-managing cancer medication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The list was developed following a literature search conducted in Cochrane Library and MEDLINE (PubMed) databases. The Capacity, Motivation and Opportunity (CMO) model developed for people living with HIV was used as theoretical framework to organise the pharmacist-led interventions emerging from literature. A panel of experts (hospital pharmacists with experience in oncology) selected through national hospital pharmacy societies was invited to participate in a consensusseeking Delphi survey, focusing on the most important and feasible interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 28 experts answered and rated 39 interventions. Whilst 35 of the proposed pharmacist-led interventions were considered important (median score above 8, on a scale of 1 to 9, without disagreement among experts), only eight were considered feasible for implementation in practice. The most frequently mentioned reasons for others not to be feasible were understaffing and excessive workload. Nevertheless, there were interventions considered vital for patients\u2019 care and hence kept in the final taxonomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Future hospital-based studies should incorporate this taxonomy based on the CMO model to measure pharmacists\u2019 interventions in real clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1772293","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:48:23Z","timestamp":1773038903000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Capacity, motivation, and opportunity model-derived taxonomy of pharmacist-led interventions applicable to people self-managing cancer medication"],"prefix":"10.3389","volume":"14","author":[{"given":"Joana","family":"Ribeiro","sequence":"first","affiliation":[{"name":"Public Health and Medicines Use, Research Institute for Medicines (iMED), Faculty of Pharmacy, University of Lisbon","place":["Lisbon, Portugal"]}]},{"given":"Ram\u00f3n","family":"Morillo-Verdugo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Clinical Management, Valme University Hospital","place":["Seville, Spain"]}]},{"given":"Filipa","family":"Alves da Costa","sequence":"additional","affiliation":[{"name":"Public Health and Medicines Use, Research Institute for Medicines (iMED), Faculty of Pharmacy, University of Lisbon","place":["Lisbon, Portugal"]}]}],"member":"1965","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00520-003-0539-4","article-title":"From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care","volume":"12","author":"Liekweg","year":"2004","journal-title":"Support Care Cancer"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.7399\/fh.11389","article-title":"A new definition and refocus of pharmaceutical care: the barbate document","volume":"44","author":"Morillo-Verdugo","year":"2020","journal-title":"Farm Hosp"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1592\/phco.28.6.816","article-title":"The definition of clinical pharmacy","volume":"28","year":"2008","journal-title":"Pharmacotherapy"},{"key":"ref4","volume-title":"El modelo CMO en consultas externas de Farmacia Hospitalaria","author":"Hern\u00e1ndez","year":"2016"},{"key":"ref5","author":"Morillo-Verdugo","year":"2019"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7399\/fh.10947","article-title":"Evaluation of HIV+ patients experience with pharmaceutical care based on AMO-methodology","volume":"42","author":"De Gracia Cantillana-Su\u00e1rez","year":"2018","journal-title":"Biomed Instrum Technol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"544","DOI":"10.7399\/fh.2016.40.6.10567","article-title":"Development of a taxonomy for pharmaceutical interventions in HIV+ patients based on the CMO model","volume":"40","author":"Morillo-Verdugo","year":"2016","journal-title":"Farm Hosp"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1461473","DOI":"10.3389\/fphar.2024.1461473","article-title":"Transforming respiratory diseases management: a CMO-based hospital pharmaceutical care model","volume":"15","author":"Zarate-Tamames","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e1004","DOI":"10.23938\/ASSN.1004","article-title":"Effectiveness on adherence to biological drugs and experience of a pharmaceutical intervention based on CMO model in patients with rheumatic disease (AdhER-2 study)","volume":"45","author":"Caso-Gonz\u00e1lez","year":"2022","journal-title":"An Sist Sanit Navar"},{"key":"ref10","volume-title":"Adaptaci\u00f3n del Modelo de Atenci\u00f3n Farmac\u00e9utica CMO al Paciente con Neoplasias Oncol\u00f3gicas y Hematol\u00f3gicas","author":"Marcos-Rodr\u00edguez","year":"2020"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.sapharm.2025.05.009","article-title":"Stratification tools in pharmaceutical care using the capacity\u2013motivation\u2013opportunity framework: a scoping review","volume":"21","author":"Morillo-Verdugo","year":"2025","journal-title":"Res Social Adm Pharm"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"ref13","first-page":"24","article-title":"A meta-analysis of group side effects in electronic brainstorming: more heads are better than one","volume-title":"International Journal of e-Collaboration (IJeC)","author":"Dennis","year":"2016"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jclinepi.2019.09.001","article-title":"Frandsen et al. provide insights to PubMed coverage across all Cochrane review groups, but more in-depth analyses would further help inform database choices","volume":"116","author":"Metzendorf","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"ref15","volume-title":"The Rand\/UCLA Appropriateness Method User\u2019s Manual","author":"Fitch","year":"2001"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e0304651","DOI":"10.1371\/journal.pone.0304651","article-title":"Delphi studies in social and health sciences\u2014recommendations for an interdisciplinary standardized reporting (DELPHISTAR). Results of a Delphi study","volume":"19","author":"Niederberger","year":"2024","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/1078155220976801","article-title":"Impact of clinical pharmacy in oncology and hematology centers: a systematic review","volume":"27","author":"Oliveira","year":"2021","journal-title":"J Oncol Pharm Pract"},{"key":"ref18","first-page":"29","volume-title":"Farmacia Hospitalaria","author":"Su\u00f1\u00e9","year":"2002"},{"key":"ref19","volume-title":"Procedimentos de ced\u00eancia de medicamentos no ambulat\u00f3rio hospitalar","year":"2012"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"CD007568","DOI":"10.1002\/14651858.CD007568.pub2","article-title":"Telephone interventions for symptom management in adults with cancer","volume":"6","author":"Ream","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.3747\/co.26.4713","article-title":"Multidisciplinary care of breast cancer patients: a scoping review of multidisciplinary styles, processes, and outcomes","volume":"26","author":"Shao","year":"2019","journal-title":"Curr Oncol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"T384","DOI":"10.1016\/j.farma.2025.05.002","article-title":"Qualitative study on the adoption and enhancement of the capacity-motivation-opportunity model for pharmaceutical care in outpatient pharmacy consultations in Spain","volume":"49","author":"\u00c1lvarez D\u00edaz","year":"2025","journal-title":"Farm Hosp"},{"key":"ref23","volume-title":"Accelerating the Uptake of Digital Solutions by the Health and Care Workforce in the WHO European Region","year":"2025"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/eurpub\/ckaf016","article-title":"Digital health literacy among the Spanish population: a descriptive and latent class analysis study","volume":"35","author":"Encuentra","year":"2025","journal-title":"Eur J Pub Health"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.3390\/ijerph19074225","article-title":"Health literacy in Portugal: results of the health literacy population survey project 2019\u20132021","volume":"19","author":"Arriaga","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1200\/JOP.18.00581","article-title":"2018 Hematology\/oncology pharmacist association best practices for the management of oral oncolytic therapy: pharmacy practice standard","volume":"15","author":"Mackler","year":"2019","journal-title":"J Oncol Pract"},{"key":"ref27","volume-title":"EU Country Cancer Profile: Portugal 2023","year":"2023"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s11096-022-01520-6","article-title":"A systematic review and pooled prevalence of burnout in pharmacists","volume":"45","author":"Dee","year":"2023","journal-title":"Int J Clin Pharm"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.18549\/PharmPract.2021.4.2559","article-title":"What drives pharmacists\u2019 turnover intention: a systematic review","volume":"19","author":"Thin","year":"2021","journal-title":"Pharm Pract (Granada)"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1772293\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:48:25Z","timestamp":1773038905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1772293\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":29,"alternative-id":["10.3389\/fpubh.2026.1772293"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1772293","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"article-number":"1772293"}}